EMAGIN CORPORATION

                         SECURED NOTE PURCHASE AGREEMENT


          THIS SECURED NOTE PURCHASE  AGREEMENT  (this  "Agreement")  is entered
into as of  November  27,  2001,  by and among  eMagin  Corporation,  a Delaware
corporation  (the "Company"),  and each of the investors as may be listed,  from
time to time, on Schedule A attached hereto (each an "Investor" or collectively,
the "Investors").

          The parties hereby agree as follows:

          1.  Purchase  and  Sale  of  Secured  Notes;   Issuance  of  Warrants.

          (a) (i) The Company has duly  authorized for sale,  issue and delivery
the secured  convertible  notes (the  "Notes") for a total  aggregate  principal
amount not to exceed  $1,500,000  (the  "Maximum Note  Amount"),  all such Notes
shall be due and  payable  on August  30,  2002 (the  "Maturity  Date")  (unless
prepaid or converted prior to such date pursuant to the terms of such Notes) and
shall  otherwise  be  substantially  in the form  attached to this  Agreement as
Exhibit A. Each Note shall be issued to an Investor  pursuant to this  Agreement
in the principal  amounts set forth on Schedule A opposite each such  Investor's
name.  The total  aggregate  principal  amount of Notes to be sold,  issued  and
delivered by the Company at the Initial  Closing (as such term is defined below)
shall not exceed $875,000.

               (ii) The Company has duly authorized for sale, issue and delivery
the three year  warrants  (the  "Warrants"  and together  with the Notes and any
Common Stock (defined below) issued thereunder, the "Securities") to purchase up
to 652,176 shares,  subject to adjustment (the "Maximum  Warrant Amount") of the
Company's  common stock,  par value $.001 per share (the "Common  Stock"),  such
Warrants to be  substantially  in the form attached to this Agreement as Exhibit
B. The total aggregate amount of shares of Common Stock to be issued pursuant to
the  Warrants  to be sold,  issued and  delivered  by the Company at the Initial
Closing shall not exceed 359,590 shares of Common Stock.

          (b) Subject to the terms of this  Agreement,  each Investor  agrees to
purchase,  and the Company agrees to issue to each Investor, a Note and Warrants
for a purchase price and amount as set out on Schedule A attached hereto.

          (c) The initial purchase and sale of the Notes and Warrants shall take
place concurrently with the execution of this Agreement (the "Initial Closing").
At the  Initial  Closing,  the Company  shall  deliver to each  Investor  (i) an
executed  counterpart  to  this  Agreement  and  (ii) a Note  in the  respective
principal  amount  specified  opposite  each  Investor's  name under the heading
"Commitment" on Schedule A attached hereto, in all cases against delivery to the
Company by the Investor of (x) an executed counterpart to this Agreement and (y)
the  respective



purchase price of each such Note and the Warrants in the amount described in the
preceding clause (ii) by bank wire transfer of immediately available funds to an
account designated in writing by the Company.

          (d) At the Initial  Closing,  the Company will promptly  issue to each
Investor a Warrant to purchase such number of shares, subject to adjustment,  as
specified  opposite each Investor's name under the heading  "Warrant  Amount" on
Schedule A attached  hereto,  each such  Warrant to have an  exercise  price per
share equal to 120%  closing  price of the Common  Stock on the  American  Stock
Exchange  (or the  over-the-counter  market)  for the  trading  day  immediately
preceding  the date of the Initial  Closing (the  "Warrant  Exercise  Price") as
reported by the Wall Street Journal, New York City edition;  provided,  however,
that at no time  shall  the  Company  be  obligated  to issue  Warrants  if such
issuance  would result in any Investor  being able to acquire more than 19.9% of
the  Company's  outstanding  Common  Stock  upon  exercise  of the  Warrants  in
contravention  of the  rules  of  the  American  Stock  Exchange  or  any  other
self-regulatory  organization  constituting the principal trading market for the
Common Stock.  The Warrants shall be  substantially in the form attached to this
Agreement as Exhibit B.

          (e) Subsequent to the Initial  Closing and prior to the Maturity Date,
provided that the respective Maximum Note Amount and Maximum Warrant Amount have
not been issued by the Company and subject to the last  sentence of this Section
1(e),  the Company  may, at its sole  discretion,  agree to permit  Investors or
additional  Investors to subscribe  for  additional  Notes  (provided  each such
additional  Note shall have a  principal  amount of not less than  $25,000)  and
related Warrants,  substantially on the same terms as Sections 1(c) and (d) (and
provided that each such additional  Note and Warrant,  as the case may be, shall
be issued on the same terms (other than recipient, date and amount) as the Notes
and  Warrants  issued by the Company at the Initial  Closing)  until the Maximum
Note Amount and the  Maximum  Warrant  Amount  have been issued by the  Company;
provided further that no additional Notes or Warrants shall be issued under this
Section 1(e) unless each  transferee  thereof shall have  concurrently  with the
entering into of this Agreement, entered into the Security Agreement (as defined
in Section  4(a)).  The  closing of each  additional  subscription  of Notes and
Warrants (the "Additional  Closings")  pursuant to this Section 1(e) shall occur
at such place and time as may be agreed upon by such  additional  Investors  and
the Company;  provided that no Additional Closings shall occur after January 31,
2002. Any additional  Notes or Warrants  issued up to the Maximum Note Amount or
the Maximum Warrant Amount, as the case may be, under this Section 1(e) shall be
restricted to issuances to  shareholders of record of the Company on the date of
the Initial  Closing unless such issuance is approved by 75% (in dollar terms of
the principal amount) of the holders of Notes as of the Initial Closing date.

          (f)  Notwithstanding  anything  to  the  contrary  contained  in  this
Agreement or any Notes issued hereunder,  if each of the initial Investors shall
not have delivered to the Company wire directions or other evidence satisfactory
to the Company, acting reasonably,  of irrevocable instruction to its respective
banking or  financial  institutions  to transfer  and  deliver to the  Company's
account,  by wire transfer or otherwise,  the amounts due from each such initial
Investor at the Initial  Closing  pursuant to Section 1(a) above (and  amounting
to, in the aggregate, $750,000, in immediately available funds), by the close of
business on November 28, 2001,  then this  Agreement and any Notes issued hereby
(including  any schedules or exhibits  attached

                                      -2-


hereto)  shall be null and void,  and of no further  force and  effect,  and any
amounts,  if any,  received by the Company from any initial Investor pursuant to
this  Agreement  or such Notes shall be promptly  (and in any case no later than
the close of business on the immediately following business day) returned by the
Company  to such  respective  initial  Investors  in such  amounts  as may  have
transferred to the Company by such initial Investors;  provided, that, any Notes
or Warrants  issuable  hereunder to such initial Investors shall not be required
to be released or issued by the Company to each such initial Investor unless and
until the  respective  amounts due in respect of such Notes and  Warrants  shall
have been actually received by the Company.

          2. Representations and Warranties of the Investors.  As of the date of
Initial Closing or of the Additional  Closing, as the case may be, each Investor
severally  as to itself and not jointly  hereby  represents  and warrants to the
Company as follows:

          (a) Such  Investor is acquiring its  respective  Note and will acquire
its respective Warrants for the Investor's own account, not as nominee or agent,
for  investment  and not with a view to, or for resale in connection  with,  any
distribution or public offering thereof within the meaning of the Securities Act
of 1933, as amended (the  "Securities  Act"). By executing this Agreement,  such
Investor  further  represents  that the  Investor  does  not have any  contract,
undertaking, agreement or arrangement with any person to sell, transfer or grant
participation  to any such person or to any third  person,  with  respect to the
Securities.

          (b) Such Investor  understands  that (i) the Securities  have not been
registered  under either the Securities Act or the securities  laws of any state
of the  United  States by  reason of  specific  exemptions  therefrom,  (ii) the
Securities  must be held by the  Investor  indefinitely,  and,  therefore,  such
Investor must bear the economic risk of such investment  indefinitely,  unless a
subsequent  disposition  thereof is registered  under the Securities Act and the
securities  laws of any applicable  state or is exempt from such  registrations;
(iii) each  certificate  that  represents the  Securities  will be endorsed with
legends as required by  applicable  securities  laws;  and (iv) the Company will
instruct  any  transfer  agent  not  to  register  the  transfer  of  any of the
Securities  unless  the  conditions   specified  in  the  foregoing  legend  are
satisfied.  For greater certainty,  the restrictive legend referred to in clause
(iii) shall be substantially in the following form:

     THIS SECURITY (A) HAS NOT BEEN REGISTERED  UNDER THE SECURITIES ACT OF
     1933, AS AMENDED (THE "SECURITIES ACT"), OR THE SECURITIES LAWS OF ANY
     STATE, AND IS BEING OFFERED AND SOLD PURSUANT TO AN EXEMPTION FROM THE
     REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND SUCH LAWS, AND (B)
     MAY NOT BE SOLD,  OFFERED  FOR SALE,  PLEDGED OR  HYPOTHECATED  IN THE
     ABSENCE OF AN EFFECTIVE  REGISTRATION  STATEMENT  UNDER THE SECURITIES
     ACT OR AN OPINION OF COUNSEL  SATISFACTORY  TO THE BORROWER  THAT SUCH
     REGISTRATION IS NOT REQUIRED.

          (c) Such Investor has been  furnished with such materials and has been
given  access to such  information  relating to the Company as the  Investor has
requested.  Such  Investor has been  afforded the  opportunity  to ask questions
regarding the Company and the Securities as

                                      -3-



the Investor has found necessary to make an informed investment  decision.  Such
Investor has been solely responsible for its own due diligence  investigation of
the Company and its  business,  for its own  analysis of the merits and risks of
its  investment  made pursuant to this Agreement and for its own analysis of the
terms of its investment.

          (d) Such Investor is an  "accredited  investor"  within the meaning of
Rule 501 under the  Securities  Act. The Investor is in a financial  position to
hold the  Securities  and is able to bear the  economic  risk  and  withstand  a
complete  loss of the  Investor's  investment  in the  Securities.  The Investor
recognizes that the Securities  involve a high degree of risk. The Investor is a
sophisticated   investor,  is  able  to  fend  for  itself  in  the  transaction
contemplated  by this  Agreement,  and has  such  knowledge  and  experience  in
financial and business  matters that the Investor is capable of  evaluating  the
merits and risks of the prospective investment in the Securities.

          (e) (i) Such Investor has the requisite  corporate power and corporate
authority to enter into and perform its obligations  under this Agreement,  (ii)
the  execution  and  delivery  of  this   Agreement  by  the  Investor  and  the
consummation  by it of the  transactions  contemplated  hereby  have  been  duly
authorized  by  all  necessary  corporate  action  and  no  further  consent  or
authorization  of the  Investor or its Board of  Directors  or  stockholders  is
required,  and (iii) this Agreement has been duly executed and delivered by such
Investor  and  constitutes  a valid  and  binding  obligation  of the  Investor,
enforceable  against the Investor in accordance with its terms,  except, in each
case,  as  such   enforceability  may  be  limited  by  applicable   bankruptcy,
insolvency,    reorganization,    moratorium,   liquidation,    conservatorship,
receivership or similar laws relating to, or affecting generally the enforcement
of, creditors'  rights and remedies or by other equitable  principles of general
application.

          (f) During the  period  such  Investor  holds any Note,  neither  such
Investor nor any person  acting on its behalf (i) has the intention of entering,
or will enter into, any put option,  short position or other similar  instrument
or position  with respect to the Common Stock that may be acquired upon exercise
of the Warrants or the conversion of the Notes or (ii) will use shares of Common
Stock that may be acquired  upon  exercise of the Warrants or the  conversion of
the Notes to settle any put option,  short position or other similar  instrument
or  position  that may have been  entered  into prior to the  execution  of this
Agreement.

          3.   Representations  and  Warranties  of  the  Company.  The  Company
represents    and   warrants   to   each   of   the    Investors   as   follows:

          (a)   Organization,   Good  Standing  and  Power.  The  Company  is  a
corporation duly  incorporated,  validly existing and in good standing under the
laws of the State of Delaware and has all requisite  corporate authority to own,
lease and operate its  properties and assets and to carry on its business as now
being  conducted.  The Company is duly  qualified  to do business and is in good
standing as a foreign  corporation in every  jurisdiction in which the nature of
the  business  conducted  or  property  owned  by it  makes  such  qualification
necessary,  other than those in which the failure so to qualify would not have a
Material Adverse Effect. As used in this Agreement,  a "Material Adverse Effect"
shall  mean any  adverse  effect on the  business,  operations,  properties,  or
financial  condition  of the Company that is material and adverse to the

                                      -4-



Company  and  its  subsidiaries,   taken  as  a  whole,  and/or  any  condition,
circumstance, or situation that would prohibit or otherwise materially interfere
with the ability of the Company to perform any of its material obligations under
this Agreement or the Securities.

          (b)  Authorization,  Enforcement.  (i) The Company  has the  requisite
corporate  power  and  corporate   authority  to  enter  into  and  perform  its
obligations  under  this  Agreement  and  the  Securities,   pursuant  to  their
respective  terms,  (ii) the  execution  and delivery of this  Agreement and the
Securities  by the  Company  and  the  consummation  by it of  the  transactions
contemplated  hereby and  thereby  have been duly  authorized  by all  necessary
corporate  action and no further consent or  authorization of the Company or its
Board  of  Directors  or  stockholders  is  required,  and  (iii)  each  of this
Agreement,  the Notes,  and the  Warrants  when  executed  and  delivered by the
Company  will  constitute  a  valid  and  binding  obligation  of  the  Company,
enforceable  against the Company in accordance with its terms,  except,  in each
case,  as  such   enforceability  may  be  limited  by  applicable   bankruptcy,
insolvency,    reorganization,    moratorium,   liquidation,    conservatorship,
receivership or similar laws relating to, or affecting generally the enforcement
of, creditors'  rights and remedies or by other equitable  principles of general
application.

          (c)  Capitalization.  The  authorized  capital  stock  of the  Company
consists of 100,000,000  shares of Common Stock, of which 25,171,183  shares are
issued and outstanding and 10,000,000 shares of preferred stock, par value $.001
per share, of which no shares are issued and outstanding. All of the outstanding
shares of the  Company's  Common  Stock have been duly  authorized  and  validly
issued and are fully paid and  non-assessable and were issued in accordance with
the  registration  or  qualification  provisions of the  Securities  Act and any
relevant state securities laws or pursuant to valid exemptions therefrom. Except
as set forth in this  Agreement  and as set forth in the SEC  Documents  and the
attached  Schedule  3(c),  no shares of Common Stock are entitled to  preemptive
rights or  registration  rights and there are no outstanding  options,  warrant,
scrip, rights to subscribe to, calls or commitments of any character  whatsoever
relating to, or securities  or rights  convertible  into,  any shares of capital
stock of the Company. Furthermore,  except as set forth in this Agreement and as
set forth in the SEC  Documents  and the attached  Schedule  3(c),  there are no
contracts, commitments,  understandings, or arrangements by which the Company is
or may  become  bound to issue  additional  shares of the  capital  stock of the
Company or  options,  securities  or rights  convertible  into shares of capital
stock of the Company. The Company is not a party to, and it has no knowledge of,
any  agreement  restricting  the voting or transfer of any shares of the capital
stock of the Company.  Except as set forth in the SEC  Documents,  the offer and
sale of all capital stock, convertible securities,  rights, warrants, or options
of the Company issued prior to the Initial Closing  complied with all applicable
federal and state  securities laws, and no stockholder has a right of rescission
or damages with respect thereto which would have a Material Adverse Effect.  The
Company has filed as exhibits to the SEC  Documents  true and correct  copies of
the Company's  articles or certificate of incorporation as in effect on the date
hereof (the "Charter"), and the Company's bylaws as in effect on the date hereof
(the  "Bylaws").  The  Company  has  not  received  any  notice  from  the  AMEX
questioning or threatening  the continued  inclusion of the Common Stock on such
market.


                                      -5-

          (d) Issuance of Securities.  The Notes and Warrants (and the shares of
Common Stock  underlying  such  Warrants) to be issued under this Agreement have
been duly  authorized by all necessary  corporate  action and, when paid for and
issued in accordance with the terms of the Notes and Warrants,  the Common Stock
issued on  exercise of the  Warrants  and the  conversion  of the Notes shall be
validly issued and outstanding, fully paid and non-assessable.

          (e) No Conflicts.  The  execution,  delivery and  performance  of this
Agreement by the Company and the consummation by the Company of the transactions
contemplated  herein  do not and  will  not (i)  violate  any  provision  of the
Company's Charter or Bylaws,  (ii) conflict with, or constitute a default (or an
event which with notice or lapse of time or both would become a default)  under,
or  give to  others  any  rights  of  termination,  amendment,  acceleration  or
cancellation of, any agreement,  mortgage, deed of trust, indenture, note, bond,
license,  lease  agreement,  instrument  or obligation to which the Company is a
party,  (iii) create or impose a lien,  charge or encumbrance on any property of
the Company  under any  agreement  or any  commitment  to which the Company is a
party or by which  the  Company  is  bound  or by  which  any of its  respective
properties  or assets are bound,  or (iv) result in a violation  of any federal,
state, or local statute, rule, regulation,  order, judgment or decree (including
any federal or state securities laws and regulations)  applicable to the Company
or any of its  subsidiaries  or by which any property or asset of the Company or
any of its subsidiaries are bound or affected.  To the knowledge of the Company,
the  business of the  Company and its  subsidiaries  is not being  conducted  in
violation of any laws,  ordinances or  regulations of any  governmental  entity,
except for possible  violations  which singularly or in the aggregate do not and
will not have a Material  Adverse Effect.  The Company is not required under any
federal,  state  or  local  law,  rule or  regulation  to  obtain  any  consent,
authorization or order of, or make any filing or registration with, any court or
governmental  agency in order for it to  execute,  deliver or perform any of its
obligations under this Agreement, or issue and sell the Securities in accordance
with the terms hereof  (other than any filings  which may be required to be made
by the Company with the SEC or state securities administrators subsequent to the
Initial  Closing  and any  registration  statement  which may be filed  pursuant
hereto); provided that, for purpose of the representation made in this sentence,
the  Company  is  assuming  and  relying  upon  the  accuracy  of  the  relevant
representations and agreements of each Investor herein.

          (f)  SEC  Documents,   Financial  Statements.   The  Common  Stock  is
registered  pursuant to Section 12 of the Exchange Act, and, except as disclosed
in the SEC  Documents,  the Company  has timely  filed all  reports,  schedules,
forms,  statements and other documents  required to be filed by it with the U.S.
Securities  and  Exchange  Commission  (the  "SEC")  pursuant  to the  reporting
requirements of the Exchange Act,  including  material filed pursuant to Section
13(a) or 15(d) of the  Exchange  Act  (all of the  foregoing  including  filings
incorporated  by  reference  therein  being  referred  to  herein  as  the  "SEC
Documents").  The  Company has  directed  the  Investor to accurate  and readily
accessible sources of true and correct copies of the SEC Documents.  As of their
respective  filing dates,  the SEC Documents  complied in all material  respects
with the  requirements of the Exchange Act or the Securities Act, as applicable,
and the rules and  regulations of the SEC promulgated  thereunder  applicable to
such  documents,  and,  as of their  respective  filing  dates,  none of the SEC
Documents  contained any untrue statement of a material fact or omitted to state
a material fact required to be stated  therein or necessary in order to make the
statements  therein,  in light of the circumstances  under which they were made,
not

                                      -6-



misleading.  The  financial  statements  of the  Company  included  in  the  SEC
Documents comply as to form in all material respects with applicable  accounting
requirements under the United States Generally Accepted  Accounting  Principles,
as those  conventions,  rules and  procedures  are  determined  by the Financial
Accounting Standards Board ("GAAP"),  and the published rules and regulations of
the SEC or other applicable  rules and regulations  with respect  thereto.  Such
financial  statements  have been prepared in  accordance  with GAAP applied on a
consistent  basis  during the periods  involved  (except (i) as may be otherwise
indicated in such financial  statements or the notes thereto or (ii) in the case
of unaudited interim statements, to the extent they may not include footnotes or
may be  condensed  or summary  statements),  and fairly  present in all material
respects the financial  position of the Company and its  subsidiaries  as of the
dates thereof and the results of operations  and cash flows for the periods then
ended (subject,  in the case of unaudited  statements,  to normal year-end audit
adjustments).

          (g)  Disclosure.  The Company has provided  each Investor with all the
information  reasonably available to it without undue expense that such Investor
has  requested for deciding  whether to purchase the Notes and Warrants.  To the
best of the  Company's  knowledge,  none of this  Agreement,  other  agreements,
written statements or certificates made or delivered in connection  herewith and
the SEC Documents,  when taken in the  aggregate,  as of the date of the Initial
Closing  contains any untrue  statement  of a material  fact or omits to state a
material fact necessary to make the statements herein or therein not misleading.

          (h) No Liens.  Other than in respect of leased tangible equipment used
by the Company in the  ordinary  course of  business,  the Company is, as of the
Closing,  the owner of all  Collateral  (as such term is defined in the Security
Agreement  referred to in Section 4(a) of this Agreement) free from any security
interest,  deed of trust,  mortgage,  pledge, lien, claim, charge,  encumbrance,
title retention  agreement,  lessor's interest in a financing lease or analogous
instrument, in, of, or on the Company's property (other than Permitted Liens, as
such term is defined in the Security  Agreement)  and the Company has not issued
or committed to issue any indebtedness ranking equal to or higher in priority to
the  security  interests  to be granted  in the  Collateral  under the  Security
Agreement to secure the obligations under the Notes.

          (i) Creditor Actions.  The Company has not received any written notice
of  foreclosure,  involuntary  bankruptcy  or other  material  adverse  creditor
actions   against  the  Company  and  has  no  actual   knowledge  of  potential
foreclosure,  involuntary  bankruptcy or other material adverse creditor actions
affecting the Company.

          (j) Patents. To the best of the Company's  knowledge,  (i) the Company
has  not  received  any  written  notice  of any  claim  from  any  third  party
(including,  without  limitation,  any governmental or regulatory entity) and no
such third party claims are pending  challenging the right of the Company to use
the patents  (collectively,  the "Security Agreement Patents") listed on Annex G
to the Security Agreement (as defined in Section 4(a)) or alleging any violation
or infringement by the Company thereof,  and (ii) each Security Agreement Patent
shown as  registered,  filed,  issued or applied  for, has been duly and validly
registered  in,  filed in or issued by,  the  official  governmental  registrars
and/or  issuers of patents and trademarks and remain in full force and effect as
of the date of the Initial Closing without any material defect.

                                      -7-


          (k) Litigation.  The Company is not party to or aware of any actual or
asserted litigation claims filed in any court that in the aggregate could result
in damages in excess of $500,000.

          4. Miscellaneous.

          (a)  Security.  The  Notes  shall be  secured  by a  general  security
interest  under a Security  Agreement (the  "Security  Agreement"),  dated as of
November 20, 2001, between the Company, as assignor of the security interest and
Verus Support  Services Inc., as collateral  agent for the Investors,  with such
security  granted for the ratable  benefit of all of the Investors as holders of
the Notes. Reference is hereby made to the Security Agreement for a statement of
the rights and  obligations of the  Investors,  and the nature and extent of the
security for, the Notes.

          (b) Fees and  Expenses.  Each party  shall pay all of its own fees and
expenses related to the transactions contemplated by this Agreement.

          (c)  Survival.   The   representations,   warranties,   covenants  and
agreements made herein shall survive the date of the Initial Closing or the date
of Additional Closing, as the case may be.

          (d) Entire  Agreement;  Amendment.  This Agreement,  including but not
limited to the form of Note (attached  hereto as Exhibit A), the form of Warrant
(attached hereto as Exhibit B), the form of Security Agreement  (attached hereto
as Exhibit C), the form of Registration  Rights  Agreement  (attached  hereto as
Exhibit D) and the other schedules and exhibits  attached  hereto,  all of which
form a part of this Agreement,  contain the entire  understanding of the parties
with respect to the matters covered hereby and, except as specifically set forth
herein, neither the Company nor any Investor make any representations, warranty,
covenant or  undertaking  with  respect to such  matters.  No  provision of this
Agreement may be waived or amended other than by a written  instrument signed by
the party against whom  enforcement  of any such  amendment or waiver is sought;
provided that the addition of  additional  Investors as per Section 1(e) of this
Agreement and any requisite related  amendments to Schedule A may be effected by
the Company without the consent of the Investors.

          (e)   Notices.   Any  notice,   demand,   request,   waiver  or  other
communication  required or permitted to be given  hereunder  shall be in writing
and shall be effective (i) upon hand delivery, overnight mail or courier service
at the address or number  designated on the signature pages hereof (if delivered
on a business  day  during  normal  business  hours  where such  notice is to be
received), or the first business day following such delivery (if delivered other
than on a business day during normal  business  hours where such notice is to be
received) or (ii) on the second  business day  following  the date of mailing by
express  courier  service,  fully  prepaid,  addressed to such address,  or upon
actual receipt of such mailing,  whichever shall first occur.  The addresses for
such  communications  shall be as set forth on the signature  pages hereof.  Any
party  hereto may from time to time  change its  address  for  notices by giving
written notice of such changed address to the other parties hereto in accordance
herewith.

                                      -8-


          (f) Waivers. No waiver by any party of any default with respect to any
provision,  condition or requirement  of this Agreement  shall be deemed to be a
continuing waiver in the future or a waiver of any other  provisions,  condition
or requirement  hereof, nor shall any delay or omission of any party to exercise
any right hereunder in any manner impair the exercise of any such right accruing
to it thereafter.

          (g) Headings.  The article,  section and  subsection  headings in this
Agreement  are for  convenience  only and  shall not  constitute  a part of this
Agreement  for any other  purpose and shall not be deemed to limit or affect any
of the provisions hereof.

          (h) No  Third  Party  Beneficiaries;  Assignment.  This  Agreement  is
intended for the benefit of the parties hereto and their  respective  successors
and  permitted  assigns  and is not for the  benefit  of, nor may any  provision
hereof be enforced  by, any other  person.  Each  Investor may assign any of its
rights under this  Agreement to any permitted  assignee of the  Securities.  The
Company  may not assign any of its rights or  obligations  under this  Agreement
without the written consent of each Investor.

          (i) Governing Law. This  Agreement  shall be governed by and construed
in accordance  with the internal laws of the State of New York,  without  giving
effect to the choice of law provisions. The Company and each Investor waives any
right to a jury trial with respect to any dispute arising out of this Agreement.

          (j)  Counterparts.  This  Agreement  may be  executed in any number of
counterparts,  all of which taken  together  shall  constitute  one and the same
instrument and shall become effective when counterparts have been signed by each
party and delivered to the other parties  hereto,  it being  understood that all
parties need not sign the same counterpart.  Execution of counterparts may be by
facsimile.

          (k)  Publicity.  The Company and the  Investors may agree upon a press
release to be issued by the Company immediately upon execution of this Agreement
describing this Agreement and the transactions contemplated hereby.  Thereafter,
any party may make a public  statement  or  announcement  with  respect  to this
Agreement  or the  transactions  contemplated  hereby or the  existence  of this
Agreement;  provided,  however,  that prior to issuing  any such press  release,
making any such public  statement  or  announcement,  such party must obtain the
prior  consent of each other  party,  which  consent  shall not be  unreasonably
withheld or delayed.

          (l) Severability.  The provisions of this Agreement are severable and,
in the  event  that  any  court  shall  determine  that  any  one or more of the
provisions or part of the provisions  contained in this Agreement shall, for any
reason,  be held to be invalid,  illegal or unenforceable  in any respect,  such
invalidity,  illegality or unenforceability shall not affect any other provision
or part of a provision of this  Agreement and this  Agreement  shall be reformed
and construed as if such invalid or illegal or unenforceable  provision, or part
of such  provision,  had never been contained  herein,  so that such  provisions
would be valid, legal and enforceable to the maximum extent possible, so long as
such  construction  does not materially  adversely effect the economic rights of
either party hereto.

                                      -9-


          (m)  Further  Assurances.  From and after the date of this  Agreement,
upon the request of the  Investors or the  Company,  each of the Company and the
Investors  shall  execute  and deliver  such  instruments,  documents  and other
writings as may be  reasonably  necessary  or desirable to confirm and carry out
and to effectuate fully the intent and purposes of this Agreement.

          5. Conditions to Initial Closing.

          It  shall  be a  condition  to the  consummation  of the  transactions
contemplated  by this  Agreement at the Initial  Closing that the Company  shall
have,  concurrently  with the  execution  of this  Agreement  by the  Investors,
executed and delivered:

          (a)  A  copy  of an  agreement  of  The  Travelers  Insurance  Company
("Travelers")  with the Company  limiting the amount of warrants to be issued to
Travelers by the Company pursuant to the Note Purchase  Agreement,  entered into
as of August 21, 2001 by the Company and Travelers,  to seventy percent (70%) of
the relevant indebtedness issued under such agreement;

          (b) to the  Collateral  Agent (as such term is  defined  therein)  the
Security  Agreement  (as defined in Section  4(a)) in the form  attached to this
Agreement as Exhibit C, and two completed originals of a UCC Form 1 suitable for
filing and the  applicable  federal  assignment  forms  executed  by the Company
sufficient for the Collateral  Agent to perfect the security  interests  created
therein;

          (c) the Registration Rights Agreement,  dated as of November 27, 2001,
by and among the Company and the Investors (the "Registration Rights Agreement")
in the form attached to this Agreement as Exhibit D;

          (d) the Warrants, each such Warrant to be in the amount required to be
issued to each Investor on the date of the Initial  Closing  pursuant to Section
1(d) and in the form attached to this Agreement as Exhibit B; and

          (e) a legal  opinion  of  Company's  counsel  to the  effect  that the
entering into of this  Agreement by the Company has been duly  authorized by all
necessary  corporate action of the Company and that the execution,  delivery and
performance  of this  Agreement by the Company will not violate or conflict with
the Amended and Restated Articles of Incorporation or Bylaws of the Company.

          6. Additional Covenants of Company.

          The Company  covenants and agrees with the Investors  that the Company
shall not issue any secured debt  (excluding  tangible  equipment  leased in the
ordinary  course of business  and  Permitted  Liens,  as defined in the Security
Agreement) or any other security  (excluding  Permitted Liens, as defined in the
Security  Agreement)  which in form or  substance  represent  or are equal to or
senior to the secured interests granted under the Security Agreement without the
approval of holders of such Notes who hold in the aggregate  seventy-five  (75%)
or more of such Notes (in terms of the  aggregate  dollar value of the principal
of the Notes then issued under this

                                      -10-



Agreement); provided that nothing in this Section 6 shall require the Company to
obtain such approval to issue  additional Notes pursuant to Section 1(e) of this
Agreement.

                            [Signature Pages Follow]

                                      -11-


          This  Agreement  has been duly  executed as of the date and year first
written above.


                         EMAGIN CORPORATION


                         By
                           -------------------------
                               Name:
                               Title:



                         INVESTORS:

                         RAINBOW GATE CORPORATION


                         By
                           -------------------------
                             Name:
                             Title:


                         MORTIMER D.A. SACKLER


                         ---------------------------
                             Mortimer D. A. Sackler

                             Address:





                         MARTIN SOLOMON


                         ---------------------------
                             Mr. Martin Solomon

                             Address:



                                      -12-



                         SOVEREIGN BANCORP LTD.


                         By
                           -------------------------
                             Name:
                             Title:


                         JAMES M. ARKOOSH


                         ---------------------------
                             Mr. James M. Arkoosh

                             Address:



                         JACK RIVKIN


                         ---------------------------
                             Mr. Jack Rivkin

                             Address:



                                      -13-



                             Schedule A - INVESTORS




Name and Address of Investor                             Commitment           Warrant Amount
                                                  (and Principal Note Amout)


- ----------------------------------------------------------------------------------------------
                                                                           
Rainbow Gate Corporation                             $ 300,000                   123,288

c/o Mundipharma House
14 Par-la-Ville Road
Hamilton HMJX, Bermuda
Attn:  Mr. Douglas Docherty

Mr. Mortimer D.A. Sackler                            $ 200,000                    82,192

Address:


Mr. Martin Solomon                                   $ 125,000                    51,370

Address:


Sovereign Bancorp Ltd.                               $ 100,000                    41,096

Bldg. #2 Chelston Pk., Ground Floor St. Michael
Barbados, West Indies
(246) 436-1002

Mr. James M. Arkoosh                                 $  25,000                    10,274

Address:








                                                                               Schedule A
                                                                                   Page 2
                                                                            
Mr. Jack Rivkin                                      $ 125,000                    51,370

Address:







                         Schedule 3(c) -- Capitalization


          The Company has  outstanding  commitments  in respect of its shares of
Common Stock ("shares") pursuant to:

          (i) various warrants  granted prior to March,  2000 at exercise prices
per share ranging from $1.72 to $26.25,  of which an aggregate of 730,172 shares
are issuable;

          (ii) the  Company's  1994 Stock  Option Plan of which an  aggregate of
1,286,000 shares are reserved for issuance;

          (iii) the  Company's  2000  Stock  Option  Plan of which a maximum  of
5,900,000 shares are authorized and available for issuance thereunder;

          (iv)  the  Company's  2001  Employee  Stock  Purchase  Plan of which a
maximum of 750,000 shares are authorized and available for issuance thereunder;

          (v) the  potential  issuance of up to 954,417  shares to The Travelers
Insurance  Company  pursuant  to the  exercise  of  certain  warrants  and/or  a
promissory  note issued under a Note Purchase  Agreement  dated as of August 20,
2001; and

          (vi)  the  potential   issuance  of  up  to  2,909,229  shares  to  SK
Corporation  pursuant to the  exercise of certain  warrants  and/or a promissory
note issued under a Securities Purchase Agreement dated as of September 18, 2001
(the "SK Purchase Agreement").





                            Exhibit A - Form of Note

                                 [See Attached]


                           Exhibit B - Form of Warrant

                                 [See Attached]



                     Exhibit C - Form of Security Agreement

                                 [See Attached]



                Exhibit D - Form of Registration Rights Agreement

                                 [See Attached]